186 related articles for article (PubMed ID: 23530192)
1. Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3.
Lui JC; Baron J
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6181-6. PubMed ID: 23530192
[TBL] [Abstract][Full Text] [Related]
2. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.
Ramani K; Mavila N; Ko KS; Mato JM; Lu SC
J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727
[TBL] [Abstract][Full Text] [Related]
4. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.
Libertini SJ; Chen H; al-Bataina B; Koilvaram T; George M; Gao AC; Mudryj M
Prostate; 2012 May; 72(6):649-60. PubMed ID: 21837779
[TBL] [Abstract][Full Text] [Related]
5. An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice.
Liao Y; Du W
J Biol Chem; 2018 Mar; 293(9):3156-3167. PubMed ID: 29330306
[TBL] [Abstract][Full Text] [Related]
6. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters.
Li X; Cui H; Sandstedt B; Nordlinder H; Larsson E; Ekström TJ
J Endocrinol; 1996 Apr; 149(1):117-24. PubMed ID: 8676043
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.
Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Golusinski W; Masternak MM
Growth Horm IGF Res; 2014 Aug; 24(4):137-41. PubMed ID: 24802266
[TBL] [Abstract][Full Text] [Related]
9. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma.
Zeng X; Yin F; Liu X; Xu J; Xu Y; Huang J; Nan Y; Qiu X
Oncol Rep; 2014 Mar; 31(3):1139-46. PubMed ID: 24402082
[TBL] [Abstract][Full Text] [Related]
11. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
[TBL] [Abstract][Full Text] [Related]
12. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3).
Santerre M; Bagashev A; Gorecki L; Lysek KZ; Wang Y; Shrestha J; Del Carpio-Cano F; Mukerjee R; Sawaya BE
J Biol Chem; 2019 Mar; 294(10):3618-3633. PubMed ID: 30591585
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.
Chen L; Chen DT; Kurtyka C; Rawal B; Fulp WJ; Haura EB; Cress WD
J Biol Chem; 2012 Nov; 287(48):40106-18. PubMed ID: 23060449
[TBL] [Abstract][Full Text] [Related]
16. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
McClellan KA; Vanderluit JL; Julian LM; Andrusiak MG; Dugal-Tessier D; Park DS; Slack RS
Mol Cell Biol; 2009 Sep; 29(17):4701-13. PubMed ID: 19564414
[TBL] [Abstract][Full Text] [Related]
17. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
Chang SW; Yue J; Wang BC; Zhang XL
Int J Clin Exp Pathol; 2015; 8(10):12853-60. PubMed ID: 26722476
[TBL] [Abstract][Full Text] [Related]
18. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
19. Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression.
He L; Yang H; Ma Y; Pledger WJ; Cress WD; Cheng JQ
J Biol Chem; 2008 Nov; 283(45):31012-20. PubMed ID: 18776222
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.
Zhao W; Wang S; Qin T; Wang W
J Cell Biochem; 2020 Jul; 121(7):3516-3525. PubMed ID: 32065448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
